Apogee Therapeutics (APGE) Other Non Operating Income (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Other Non Operating Income data on file, last reported at $8.7 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $8.7 million, up 11.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.9 million (up 588.71% YoY), and the FY2025 annual result was $30.0 million, up 996.79% from the prior year.
• Other Non Operating Income was little changed at $8.7 million in Q1 2026 per APGE's latest filing, from $8.7 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $10.3 million in Q2 2024 and troughed at -$23.3 million in Q4 2024.
• A 5-year average of $2.4 million and a median of $6.2 million in 2024 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2023 and 2024: Other Non Operating Income plunged 2682.61% in 2023, then surged 4476.69% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at $92000.0 in 2022, then sank by 2682.61% to -$2.4 million in 2023, then sank by 881.61% to -$23.3 million in 2024, then surged by 137.44% to $8.7 million in 2025, then grew by 0.1% to $8.7 million in 2026.
• Business Quant data shows APGE's Other Non Operating Income at $8.7 million in Q1 2026, $8.7 million in Q4 2025, and $6.3 million in Q3 2025.